Healthcare & Life Sciences
Precision antibody-based therapeutics for oncology
Precision antibody-based therapeutics for oncology is a Healthcare & Life Sciences startup, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About Precision antibody-based therapeutics for oncology
Precision antibody-based therapeutics for oncology is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Develops antibody-based therapeutic solutions targeting oncology indications to improve cancer treatment precision and efficacy.
Explore Precision antibody-based therapeutics for oncology's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.